San Antonio Hub To Foster Pediatric Medical Device Development

By Iris Gonzalez, Startups San Antonio The San Antonio-Austin hub of a pediatric medical device consortium ...

InCube, VelocityTX Join Work to Develop Pediatric Medical Devices

By David Holley, Xconomy Texas San Antonio—A group of San Antonio institutions are getting involved ...

BioBridge Global subsidiary acquires operations of UTHSCSA’s Allograft Resources
March 5, 2015

SAN ANTONIO - The University of Texas System Board of Regents has approved the sale and transfer of certain assets of Allograft Resources, a tissue recovery program within the UT Health Science Center at San Antonio's University Transplant Center, to GenCure®, a subsidiary of BioBridge Global.

Allograft Resources provides tissue donor recovery services, education, community outreach and bereavement support. GenCure, a sister subsidiary of the South Texas Blood & Tissue Center, provides identical services and intends to serve hospitals previously served by Allograft Resources.

"The acquisition of the UT Health Science Center's Allograft Resources tissue program by GenCure will provide a healthy future for the San Antonio and South Texas services provided for many years by Allograft Resources," said Dr. Glenn Halff, director of the University Transplant Center. "By ensuring these services remain available, we intend to respect the wishes of tissue donors and their families and the needs of our partner hospitals, with whom we've worked for many years."

To facilitate a seamless service transition from Allograft Resources, GenCure will acquire Allograft Resources operations and the majority of staff in San Antonio, the Rio Grande Valley and Laredo.

"We are honored to be entrusted to continue Allograft Resources' lifesaving work," said Michael F. Moloney, chief operating officer of GenCure. "With our ample resources and facilities, we plan to continue and enhance the tissue donation programs in the region that Allograft Resources currently serves."

Dr. Halff said transferring tissue services to GenCure will allow the Health Science Center to focus on its central mission of expanding its organ transplant programs.

"We are confident that GenCure will provide the same high level of service and support, having worked with their team under the South Texas Blood & Tissue Center name for many years," Dr. Halff said.

Moloney said GenCure is ready to serve all hospitals and tissue donor families who have had a relationship with Allograft Resources.

"The decision to donate tissue is a very personal and powerful one for families who have lost loved ones," Moloney said. "Allograft Resources donor families can expect to be brought into the GenCure fold and given the same level of care and consideration GenCure extends to its own donor families."

The transaction will make GenCure the largest tissue recovery agency in South Texas.

About GenCure: GenCure, a Texas nonprofit corporation, focuses on regenerative medicine and uses the power of human cells and tissues to inspire hope, enhance lives and enable clinical advancements. Using processed tissue and cell-based therapies, GenCure works to connect health care requirements with innovative solutions that best serve the needs of the global patient community. Visit us at

About BioBridge Global: BioBridge Global (BBG) is a San Antonio, Texas-based nonprofit corporation that offers diverse services through its subsidiaries. Its subsidiaries - the South Texas Blood & Tissue Center, QualTex Laboratories and GenCure - provide products and services including blood collection, cellular therapy, umbilical cord blood and tissue services as well as testing of blood, plasma and tissue products for clients in the United States and worldwide. BBG is an outgrowth of the South Texas Blood & Tissue Center, which has a proud history of serving the South Texas region and beyond for more than 40 years. BBG is committed to supporting groundbreaking research, addressing unmet clinical needs and enabling the development and commercialization of novel biotechnology products. Visit us at


Stay informed. Subscribe to BioMed SA news alerts.